Fair enough. You are correct about splashing the good news but staying quiet about the bad, as you say pretty common across the spec board. Again my old favourite pyc, I can’t believe how many partnerships they entered and announced with great fanfare- 1million dollars up front etc , only to be quiet for the next three years and only admit the collaborations had ended when forced to. I mentioned before we won’t even know if it actually works after phase 1, and those results must still be 9 months away if they start trial without delay. Hopefully some of these “bonus collaborations” will demonstrate real effectiveness long before we get phase 2 results. Hard to believe the new investors wouldn’t have done a fairly in depth investigation before spending 28 mil, but I guess investors can be fooled if it is just based on presentations and data created by the company without independent external validation. Hopefully scientists looking into rce can’t be fooled and find genuine value very soon. Even the USA result with COVID recently shows the compound “does something” which I thought was good
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)